chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Dose given left upper lateral thigh. Reaction notes a coupe hours later. Called office next day and provider said it was an infection, prescribed antibiotics. I was giving Tylenol, ibuprofen, Benadryl and icing area. Provider said to do warm compresses and antibiotics. Even after 2 doses of prescribed antibiotics the site is still red, warm, and firm. No fever present.
I had started to notice that I was having a shakiness in my finger and when I was walking there was an issue in my gait, and I was dragging my left leg. I also had an issue with my left arm where I was not able to hold it correctly. In January of 2023 I reached out to my health care provider, and we concluded these were tremors. She referred me to a neuroscientist, and he said that what I am experiencing is consistent with Parkinson's Disease. He did see that I was having a lack of blinking and that I am slow in my physical actions. He got me on a medication, got me an MRI on my head to see if there may be more signs with Parkinson's or if I have a stroke or something along those lines.   We did find that I blew out my right meniscus which I had surgery today to repair as well.
Date and time of vaccination: (list both if they received both shots): 2-12-21 @2pm , 3-10-21 @ 2pm. Brand and lot of vaccine:  Moderna LOT # 010N20A; Moderna LOT # (was not written on card as per caller). Date and time adverse event started: 3-18 rash to back which resolved. On 3-25-21 noticed a rash to the chest/breast area. 3/26-recommended antihistamine (claritin, benadryl, zyrtec) and informed of life threatening symptoms such as SOB, CP, difficulty breathing or diffuse rash to the body; if any lift threatening symptoms began to go to their local ER. Caller verbalized understanding.
Expired vaccine used; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Nov-2021 at 10:00 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Nov-2021 at 10:00 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 19-Nov-2021 at 10:00 AM, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided.  No treatment medications were provided.   This case was linked to MOD-2021-391981 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 23-Nov-2021: Included reporter information added, patient demographics added, dosage regimen updated and added for dose 1.
On January 30th went to the hospital. Eye and ear had inflammation on the right side of her throat and tonsils.
The patient developed a fever to 102 on 11/12/2019 and was noted to have blue cheeks while in crib.  Daycare worker picked up baby and noticed that the child's face was blue .  She also found it difficulty to wake the child.  The patient was hospitalized and an EKG and CXR were normal.  The fever resolved and the child's oral intake increased.    Normal examination on discharge
2ml of normal saline was used to dilute vaccine instead of 1.8ml of normal saline.
Rash under injection site Headache Fever 100.5 Chills Body aches
Patient received 2 Moderna booster doses during the vaccine clinic as the patient had 2 different consent forms and went to both of the vaccinators so it was unknown to the vaccinators that the patient had already received a vaccine in that same day.  The booster vaccine doses were given in different arms: 1 in the left deltoid and 1 in the right deltoid.  When discovered, the information was given to the Long-Term Care facility and she was going to contact the primary physician.  At the time which was 2 days later, the patient was doing fine.
On day 8 after the vaccine I experienced a very red, warm, somewhat itchy, raised area (oval shaped and about the size of a large orange)  at the injection site.  It was that way for two days and then began dissipating with day 4 being barely noticeable.
Kdg booster shots given 4/25/08.  Next AM, R upper arm appeared red, hot, hard to touch.  Arm was 1 1/2 x normal size.  Pt. was taken to clinic, seen by MD.  Given rx for antibiotic, steroid, and Benadryl.  Reddened area extended from over shoulder to 7" above elbow.  Sx subsiding in 24 hours.
Patient began feeling unwell and stated that she was experiencing rapid heart rate after receiving vaccine. Paramedics were called and patient was monitored in a seated position while awaiting emergency services. Patient was transported from the pharmacy via emergency services.
Arthrisitis symptoms flared up; Muscle aches; Joint pains; Chills; Headache; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRITIS (Arthrisitis symptoms flared up), MYALGIA (Muscle aches), ARTHRALGIA (Joint pains), CHILLS (Chills) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis (controlled arthritis).   On 22-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, the patient experienced ARTHRITIS (Arthrisitis symptoms flared up), MYALGIA (Muscle aches), ARTHRALGIA (Joint pains), CHILLS (Chills) and HEADACHE (Headache). At the time of the report, ARTHRITIS (Arthrisitis symptoms flared up), MYALGIA (Muscle aches), ARTHRALGIA (Joint pains), CHILLS (Chills) and HEADACHE (Headache) outcome was unknown.            No Relevant concomitant medications was reported.  Treatment information was not provided.
Extreme headache with strong vertigo (walking very dificult due to vertigo) accompanied with stomach nausea and throwing up. Still have headache and some vertigo as of 6/24 at 8:00am.
This spontaneous report as received from a pharmacist refers to a patient of unknown demographics. Patient's pertinent medical history and drug allergies were not reported. On 11-SEP-2014 the patient was vaccinated with first dose of RECOMBIVAX HB 1ml (lot # and expiry date unspecified), intramuscular. No concomitant medications were reported. On 09-DEC-2014, the patient was in the pharmacy to receive second dose of RECOMBIVAX HB. No adverse effects were reported. No product quality complaint (PQC) was reported. Causality was reported as not related to therapy with RECOMBIVAX HB. Additional information has been requested.
COVID-19; COVID-19; Flu like symptoms; This is a solicited report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): 22K-163-4482426-00.  A 77-year-old female patient received BNT162b2 (BNT162B2), in Feb2021 as dose 1, single (Batch/Lot number: unknown), in Mar2021 as dose 2, single (Batch/Lot number: unknown) and in Apr2022 as dose 3 (booster) , single (Batch/Lot number: unknown), all intramuscular for covid-19 immunisation; adalimumab (HUMIRA), (Lot number: 1162124) at citrate free, subcutaneous. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19"; INFLUENZA LIKE ILLNESS (non-serious), outcome "unknown", described as "Flu like symptoms". The action taken for adalimumab was unknown.  The reporter's assessment of the causal relationship of "covid-19" with the suspect product(s) BNT162b2 was not provided at the time of this report. Since no determination has been received, the case is managed based on the company causality assessment. The reporter considered "flu like symptoms" related to BNT162b2.  Clinical information: Solicited report by a consumer of an elderly female with events of non-serious COVID and Flu Like Symptoms with HUMIRA (Adalimumab). There was no reported medical history. On unknown dates, the patient experienced COVID and Flu Like Symptoms. PFIZER BIONTECH COVID-19 VACCINE (TOZINAMERAN) was also considered suspect. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. Causality for HUMIRA (Adalimumab) The reporter's causality for the event(s) of COVID and Flu Like Symptoms was not provided. Suspect drug (information): (include generic name) Humira (Solution for injection in pre-filled pen).  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on available information the causal relation between the events Drug ineffective, suspected Covid-19 and Influenza like illness and suspect drug BNT162b2 cannot be excluded.
After lunch (had eaten nothing out of the ordinary) my daughter developed a SoftBall sized Hive on her Right thigh near Hib vaccination site.  She continually broke out in hives ranging in sizes from pencil eraser to softball (plus)sizes across her entire body for a full seven days before subsiding. At times I estimate about 50% coverage. Very scary! Luckily, she had no breathing issues, fever, etc.  We tried giving her Childrens Benadryl to counteract the reaction however, did not seem to help.
40 minutes after the vaccine administration, I experienced numbness on the right side of my face.  Around my eye, to the side of my nose and  around my mouth, only on the right side. Also on the right side of my tongue. This resolved after an hour and a half. It reoccurred about 6 hours later, at 4:00 p.m. . And continued for 48 hours. 12 hours post vaccine, a fever as high as 102 degrees Fahrenheit, severe body aches targeting especially the lower extremities, and chills occurred. The fever and chills lasted 24 hours. The body ach es lasted 48 hours.
A few hours after receiving my first COVID vaccine I began experience joint pain. My left knee became the worst and I couldn?t even bend it. It subsided by the next day. When I told the pharmacy, they told me that people don?t experience that after the first vaccine. I told them that?s what I experienced and they told me no I didn?t. So I came here to report it. I just got my second vaccine today. So hopefully it?s not as bad.
190 patients (9 different lot numbers) received a vaccine past the beyond used by date; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. Not Provided    For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date).    No concomitant medication was reported.  190 patients (9 different lot numbers) received a vaccine past the beyond used by date.  It was unknown if patient received any other vaccines in the 4 weeks prior to the COVID-19 vaccine administration.  No treatment medication was reported.  This case pertains to the 142nd patient of the total 190 patients.   This case was linked to US-MODERNATX, INC.-MOD-2023-704335 (Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-704335:Master case
Hives, congestion, sniffles, urticaria eyelids, neck only, monitored breathing and vitals in office for hours.  Given BENADRYL 18.75 mg by mouth.  Resolved within 1 hour in office.
11 hours after vaccine started feeling chills, extreme fatigue, restless sleep at night, fainted next morning, and extremely low BP (58/38), normal 100/70. gradually came back to normal after drinking fluids and salt intake. symptoms resolved about 24 hours after immunization
I noticed I had hives on my thighs that evening. The next morning I noticed more hives on my torso while I was getting dressed.
Normal after affects for 2-3 days after shot, then totally fine. One week after shot, woke up with red, swollen arm and pain at injection site.
This spontaneous report as received from a certified medical assistant refers to a patient of unknown age and gender. On 10-APR-2015, the patient was vaccinated with an improperly stored dose of PNEUMOVAX23 (dose, route and lot # not reported). No adverse effects were reported. Additional information has been requested.
Caller states she just left the Hynes Center after her second dose of Pfizer and her arm feels heavy and there is a bump by her elbow. Instructed caller to have her PCP or another healthcare provider assess her arm since I cannot see it. Caller states she is walking back to the Hynes center to have it assessed. Caller also states that she sat for 30 minutes and her throat felt tingly, but has subsided. She alerted a healthcare professional there who observed her and cleared her to leave.
Caller mentioned that she is "getting over a cold"; the left side of her "face went numb for 10 minutes" but there was no paralysis; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A 40 year-old female patient received bnt162b2 (BNT162B2), administration date 05Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NASOPHARYNGITIS (non-serious) with onset Apr2021, outcome "unknown", described as "Caller mentioned that she is "getting over a cold""; HYPOAESTHESIA (non-serious) with onset Apr2021, outcome "recovered" (Apr2021), described as "the left side of her "face went numb for 10 minutes" but there was no paralysis.  Additional information: Patient reported that 5-6 days later, the left side of her "face went numb for 10 minutes" but there was "no paralysis".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Felt dizzy after the shot and pass out for few 5 seconds. With jerky moves of arm and regained consciousness. Also notice pallor by parent. No treatment given.C
son experienced swollen lymph nodes. Got the vaccine same day as her; This is a spontaneous report from a contactable consumer (parent). This consumer reported for a male patient that, a male patient of 44 years old received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot number was not reported, Expiry date: Unknown), dose 1 via an unspecified route of administration on 26Jul2021 as a dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced swollen lymph nodes. got the vaccine same day as her on Jul2021. The patient got her first dose of the Pfizer covid 19 vaccine last 26Jul2021, experienced diarrhea, soreness of arms, swelling of underarm (arm where she got injected) that has a knot and feels warm. Reported also that her son experienced swollen lymph nodes. Got the vaccine same day as her Asking if swollen lymph node was one of the side effects of our vaccine. Asked what they can do to ease the pain and swelling. Outcome of the event was unknown.  Information about lot/ Batch number has been requested.
I started to notice what I thought was a bug bite. It was not getting bette after a couple of days so i booked a virtual appointment. I was diagnosed with shingles 4/29/21. I?ve never had this happen before. I have had chicken pox  when I was a child but never had a flare up before. I am now on anti viral medication as of 4/29/21
Arm is sore for the past 2 months since shot painful to lift arm uncomfortable in certain positions and trying to get to sleep
HYPOXEMIA 8/15/2021 UNSPECIFIED DEMENTIA, UNSPECIFIED SEVERITY, WO BEHAVIORAL DISTURBANCE
Pt did not have an adverse event happen, the Varicella vaccine was administered twice at the same time. One MA administered on the left Deltoid and the other MA administered on the Right Deltoid.
Caused irregular menstrual spotting, cramping and bloating the following day after receiving the 2nd shot.
no additional adverse event; The patient was inadvertently administered a 4th does of GARDASIL 9.; This spontaneous report was received from a licensed practical nurse referring to a patient of unknown age and gender. Information about patient's pertinent concurrent conditions, medical history, concomitant medications and previous drug reactions or allergies was not provided.  On 27-MAR-2020, the patient was vaccinated with 4th dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection as prophylaxis (extra dose administered) (concentration, vaccination scheme frequency, route and anatomical location of administration were not reported; lot number R030456 and expiration date: 23-JUL-2021). No adverse event was reported. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.  devicelotnumber: R030456; expirationdate: 23-JUL-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Unknown; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
Information has been received from a Licensed Practical Nurse (LPN) concerning multiple unspecified patients of unknown age and gender. No concurrent condition, medical history and concomitant therapies were reported. On unspecified dates, the patients received doses of improperly stored VAQTA (lot # 015460 with expire date 20-JUL-2017 or L002717 with expire date of 02-JUN-2017, dose and route not reported). The vaccines has been exposed to temperature of 48.4 F for 50 minutes. There was no previous temperature excursion. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Patient presents with a potential reaction to the COVID19 vaccine. The patient reports a sensation of swelling around her L-sided face and neck with itching, but with no airway compromise. The patient has a history of facial swelling after a flu vaccine for which she was hospitalized. While the patient didn't have any clear sign of swelling on exam,  50mg of Benadryl IM was given as the patient had already taken OTC Zyrtec with no effect, and given her body habitus for improved absorption in a timely manner.   AMR gave  50mg IM Benadryl given in R deltoid and tolerated well. With close monitoring and above intervention, symptoms resolved and patient was returned home with her partner as the driver.
The shot was on Friday Feb. 5.  Later that  day and throughout the next day, Sat. the 6th  the left arm was mildly sore.  Also on Saturday I developed a mild headache. Then on Monday the 8th there was a mild irritation and sore red streak  in my left arm pit.    I am o negative blood type, if that makes any difference.
Narrative:  COVID infections following completion of COVID vaccine series 01/06/21 COVID vaccine dose #1 01/29/21 COVID vaccine dose #2 03/28/21 Pt presents to ED reporting right sided lower back/flank pain x2-3 days, pleuritic chest pain, and concerns of UTI; on exam, pt appears to have early shingles rash but denies ever having chicken pox; discharged with ketorolac, valacyclovir, and naproxen 03/30/21 Pt reports no shingles rash but continuing pain that is tender to palpation and worse with movement; zoster IgG is positive 04/06/21 Pt presents to clinic and reports continued sharp back pain; rx given for tylenol #3 07/29/21 Pt reports cough, diarrhea, runny nose, sore throat, and close exposure to known or suspected COVID positive person; COVID POSITIVE 07/30/21 Pt reports body aches, mild cough, runny nose; rx given for benzonatate, ascorbic acid 07/31/21 Pt reports mild cough, fatigue, diarrhea, muscle pain, runny nose 08/01/21 Pt reports loss of taste or smell 08/02/21 Pt reports continued diarrhea; advised to hold miralax and colace 08/03/21 Pt reports cough nearly resolved, fatigue 08/05/21 Pt reports worsening diarrhea and abdominal symptoms; advised to come in for evaluation; meets CDC criteria for resolution of COVID